(Q38511174)

English

A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

scientific article published on February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. (English)

1 reference

Europe PubMed Central

3 September 2017

0 references

2

object named as

Sharon B Wigal

1 reference

Europe PubMed Central

3 September 2017

Howard B. Abikoff

3

object named as

Howard Abikoff

1 reference

Europe PubMed Central

3 September 2017

author name string

James J McGough

1

1 reference

Europe PubMed Central

3 September 2017

John M Turnbow

4

1 reference

Europe PubMed Central

3 September 2017

Kelly Posner

5

1 reference

Europe PubMed Central

3 September 2017

Eliot Moon

6

1 reference

Europe PubMed Central

3 September 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

3 September 2017

Journal of Attention Disorders

1 reference

Europe PubMed Central

3 September 2017

9

1 reference

Europe PubMed Central

3 September 2017

476-485

1 reference

Europe PubMed Central

3 September 2017

3

1 reference

Europe PubMed Central

3 September 2017

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

A dose-ranging study of a methylphenidate transdermal system in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves.

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054705284089

21 January 2018

Identifiers

10.1177/1087054705284089

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38511174&oldid=1523289979"